Association of CYP17, GSTP1, and PON1 polymorphisms with the risk of prostate cancer

Dietary factors, life‐style as well as environmental conditions may contribute to the risk of prostate tumor together with genetic susceptibility, that may be an important factor in determining who is more likely to develop prostate malignancy. We have undertaken a case‐control study in order to elucidate the association between polymorphisms in some metabolizing genes with the risk of prostate cancer (PCa).

[1]  W. Haenszel,et al.  Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. , 1968, Journal of the National Cancer Institute.

[2]  E. Rimm,et al.  A prospective study of dietary fat and risk of prostate cancer. , 1993, Journal of the National Cancer Institute.

[3]  M. Waterman,et al.  Localization of the human CYP17 gene (cytochrome P450(17 alpha)) to 10q24.3 by fluorescence in situ hybridization and simultaneous chromosome banding. , 1992, Genomics.

[4]  M Feychting,et al.  Cancer in twins: genetic and nongenetic familial risk factors. , 1997, Journal of the National Cancer Institute.

[5]  J. Hayes,et al.  The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. , 1995, Critical reviews in biochemistry and molecular biology.

[6]  C. Wadelius,et al.  Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer. , 1999, Pharmacogenetics.

[7]  M. Keifer,et al.  The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin , 1996, Nature Genetics.

[8]  D. Adler,et al.  The molecular basis of the human serum paraoxonase activity polymorphism , 1993, Nature Genetics.

[9]  D. Li,et al.  Modulation of DNA modification (I-compound) levels in rat liver and kidney by dietary carbohydrate, protein, fat, vitamin, and mineral content. , 1992, Mutation research.

[10]  D. Grignon,et al.  High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases. , 1994, In vivo.

[11]  A. Whittemore,et al.  Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. , 1995, Journal of the National Cancer Institute.

[12]  A. Gardemann,et al.  The paraoxonase Leu-Met54 and Gln-Arg191 gene polymorphisms are not associated with the risk of coronary heart disease. , 2000, Atherosclerosis.

[13]  D. Shih,et al.  Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis , 1998, Nature.

[14]  F. Grodstein,et al.  Prospective study of plasma fatty acids and risk of prostate cancer. , 1994, Journal of the National Cancer Institute.

[15]  T. DeWeese,et al.  The molecular pathogenesis of prostate cancer: Implications for prostate cancer prevention. , 2001, Urology.

[16]  J. Stanford,et al.  A polymorphism in the CYP17 gene and risk of prostate cancer. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[17]  D. Forman,et al.  Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. , 1997, Carcinogenesis.

[18]  J. Joven,et al.  Regulation of serum paraoxonase activity by genetic, nutritional, and lifestyle factors in the general population. , 2003, Clinical chemistry.

[19]  H. Grönberg,et al.  Studies of genetic factors in prostate cancer in a twin population. , 1994, The Journal of urology.

[20]  T. Lehtimäki,et al.  New paraoxonase 1 polymorphism I102V and the risk of prostate cancer in Finnish men. , 2003, Journal of the National Cancer Institute.

[21]  Heredity and prostate cancer: A study of World War II veteran twins , 1997, The Prostate.

[22]  C. Wadelius,et al.  Prostate cancer associated with CYP17 genotype. , 1999, Pharmacogenetics.

[23]  B. Goldstein,et al.  Free radicals and carcinogenesis. , 1990, Free radical research communications.

[24]  D. Li,et al.  Association between diet and age-related DNA modifications (I-compounds) in rat liver and kidney. , 1990, Cancer research.

[25]  J. Brooks,et al.  Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[26]  P. Walsh,et al.  The development of human benign prostatic hyperplasia with age. , 1984, The Journal of urology.

[27]  P. Durrington,et al.  Human serum paraoxonase. , 1998, General pharmacology.

[28]  W. Weber.  Influence of heredity on human sensitivity to environmental chemicals , 1995, Environmental and molecular mutagenesis.

[29]  Taylor Murray,et al.  Cancer statistics, 2000 , 2000, CA: a cancer journal for clinicians.

[30]  C. Chen,et al.  Risk of prostate cancer in relation to polymorphisms of metabolic genes. , 2001, Epidemiologic reviews.

[31]  S. Srivastava,et al.  Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. , 1994, European journal of biochemistry.

[32]  T. Habuchi,et al.  Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect. , 2000, Cancer research.

[33]  M. Marberger,et al.  A polymorphism in the CYP17 gene is associated with prostate cancer risk , 2000, International journal of cancer.

[34]  D W Nebert,et al.  Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer. , 1996, DNA and cell biology.

[35]  O. Cussenot,et al.  Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways , 2001, Cancer.

[36]  W. Miller,et al.  Cloning and sequence of the human gene for P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): similarity with the gene for P450c21. , 1987, DNA.

[37]  F P Perera,et al.  Environment and cancer: who are susceptible? , 1997, Science.

[38]  B. Ames,et al.  Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. , 1983, Science.

[39]  S. Devesa,et al.  International trends and patterns of prostate cancer incidence and mortality , 2000, International journal of cancer.

[40]  B. Henderson,et al.  Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. , 1991, British Journal of Cancer.

[41]  T. Katoh,et al.  Impact of genetic polymorphisms of 17‐hydroxylase cytochrome P‐450 (CYP17) and steroid 5α‐reductase type II (SRD5A2) genes on prostate‐cancer risk among the Japanese population , 2001, International journal of cancer.